科病毒如何影响癌细胞的耐药性
Yuping Yang1,2, Yuwen Wang3, Zhengdong Zhou4
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Recent patents on anti-cancer drug discovery
|March 28, 2025
概括
抗癌药物耐药性是一个重大挑战,由HPV,EBV和HBV等瘤病毒加剧. 了解这些病毒与癌症的相互作用是开发新疗法克服抗性的关键.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症抗药性显著限制了化学疗法,免疫疗法和向疗法的治疗疗效.
- 瘤病毒,包括人类乳头瘤病毒 (HPV),爱斯坦-巴尔病毒 (EBV) 和乙型肝炎病毒 (HBV),都与癌症的发病,进展和治疗反应有关.
- 瘤病毒和癌细胞之间的相互作用通过影响药物有效性至关重要的细胞通路来复杂化治疗结果.
研究的目的:
- 提高对抗癌药物耐药性复杂性意识,强调瘤病毒的作用.
- 要突出oncoviruses如何影响癌症的发展和对治疗的反应.
- 强调需要了解病毒-癌症-药物相互作用,以制定新型治疗策略.
主要方法:
- 本综述综合了有关抗癌药物耐药性机制的现有研究.
- 它专门研究瘤病毒对影响药物代谢,DNA修复和瘤微环境的细胞通路的影响.
- 文献分析侧重于病毒,癌细胞和治疗剂之间的复杂相互作用.
主要成果:
- 瘤病毒可以通过改变参与药物反应的关键细胞过程来促进癌症药物耐药性.
- 了解这些病毒影响对于预测治疗结果至关重要.
- 该审查确定了关键的病毒-癌症-药物相互作用,需要进一步调查.
结论:
- 克服癌症药物耐药性需要全面了解瘤病毒的参与.
- 新的治疗策略必须考虑到病毒对治疗疗效的影响.
- 精确瘤学的进步需要对癌症,相关病毒和药物相互作用的整体看法,以改善患者的治疗结果.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...